Skip to main content

Table 2 Multivariate analysis of various inflammatory parameters

From: An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era

Inflammatory parameters OS PFS
HR (95% CI) P-value HR (95% Cl) P-value
Albumin levels(<41.5 g/L) 2.911(1.533–5.525) 0.001 2.025(1.278–3.208) 0.003
LMR(≤2.7) 1.966(1.100–3.513) 0.022 1.688(1.062–2.684) 0.027
CRP(>8.6 mg/L) 1.804(0.983–3.310) 0.037 1.588(0.993–2.541) 0.054
NLR(>4.6)   0.306   0.183
PLR(>187.4)   0.604   0.205
Fibrinogen levels (>3.8 g/L)   0.800   0.266
  1. Abbreviations: OS Overall survival, PFS Progression-free survival, HR Hazard Ratio, 95% Cl, 95% confidence limits, LMR Lymphocyte-to-monocyte Ratio, CRP C-reactive protein, NLR Neutrophil-to- lymphocyte ratio, PLR Platelet-to- lymphocyte ratio